| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 504,397 | 491,349 | 470,081 | 492,470 | | Cost of Revenue | 229,495 | 227,557 | 225,957 | 245,524 | | | Gross Profit | 274,902 | 263,792 | 244,124 | 246,946 | | | Operating Expenses | | Research Development | 24,669 | 21,265 | 22,137 | 22,560 | | Selling General and Administrative | 125,838 | 118,958 | 120,249 | 120,759 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 10,160 | 10,158 | 10,158 | 10,158 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 114,235 | 113,411 | 91,580 | 93,469 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,341 | (1,724) | (4,867) | 5,152 | | Earnings Before Interest And Taxes | 117,576 | 111,687 | 86,713 | 98,621 | | Interest Expense | 25,728 | 26,227 | 28,494 | 27,289 | | Income Before Tax | 91,848 | 85,460 | 58,219 | 71,332 | | Income Tax Expense | 27,279 | 27,363 | 18,514 | 19,233 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 64,569 | 58,097 | 39,705 | 52,099 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 64,569 | 58,097 | 39,705 | 52,099 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $64,569 | $58,097 | $39,705 | $52,099 |
|
0.51% Nasdaq 
Income Statement
